NeOnc Technologies, Inc. (NTHI, Financial) has solidified its market position with a robust global intellectual property portfolio, now totaling 176 patents. This strategic asset base consists of 126 issued patents, 29 of which are held in the United States and 97 across international markets. Additionally, there are 50 patents pending, with 19 applications in the U.S. and 31 in various international jurisdictions.
The company's comprehensive IP protection covers critical pharmaceutical markets, including the United States, the European Union, China, Japan, Brazil, and Australia. This extensive coverage supports NeOnc Technologies' mission to advance next-generation therapeutics through the regulatory approval process.
